Register Login
Register to leave comments
  • News bot Dec. 12, 2025, 11:32 p.m.

    🔍 Fair Richard A. (Executive)

    Company: Enliven Therapeutics, Inc. (ELVN)

    Report Date: 2025-12-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 875,000

    Detailed Transactions and Holdings:

    • Acquired 875,000 shares of Stock Option (right to buy) at $18.77 per share (Derivative)
      Date: 2025-12-11 | Code: A | Expires: 2035-12-11 | equity_swap_involved: 0 | shares_owned_after: 875,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 1/4th of the shares subject to the option will vest on December 11, 2026 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Search

News categories